Terms: = Kidney tumors AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
74 results:
1. Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal tumors: A Multicenter Study.
Luo S; Lin W; Wu J; Zhang W; Kui X; Lai S; Wei R; Pang X; Wang Y; He C; Liu J; Yang R
Acad Radiol; 2024 Apr; 31(4):1460-1471. PubMed ID: 37945492
[TBL] [Abstract] [Full Text] [Related]
2. Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma.
Yang S; Jian Y; Yang F; Liu R; Zhang W; Wang J; Tan X; Wu J; Chen Y; Zhou X
Abdom Radiol (NY); 2024 Jan; 49(1):182-191. PubMed ID: 37907684
[TBL] [Abstract] [Full Text] [Related]
3. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
[No Abstract] [Full Text] [Related]
5. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
[TBL] [Abstract] [Full Text] [Related]
6. [Value of clear cell likelihood score in differentiation between renal oncocytoma and clear cell renal cell carcinoma].
Cui MQ; He B; Xu W; Hao YW; Ding XH; Wang S; Bai X; Liu BC; Ye HY; Wang HY
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3779-3785. PubMed ID: 36517429
[No Abstract] [Full Text] [Related]
7. CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis.
Dehghani Firouzabadi F; Gopal N; Homayounieh F; Anari PY; Li X; Ball MW; Jones EC; Samimi S; Turkbey E; Malayeri AA
Clin Imaging; 2023 Feb; 94():9-17. PubMed ID: 36459898
[TBL] [Abstract] [Full Text] [Related]
8. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.
Erlmeier F; Sun N; Shen J; Feuchtinger A; Buck A; Prade VM; Kunzke T; Schraml P; Moch H; Autenrieth M; Weichert W; Hartmann A; Walch A
Oncology; 2023; 101(2):126-133. PubMed ID: 36198279
[TBL] [Abstract] [Full Text] [Related]
9. Algorithm-Based Approach to the Histological Routine diagnosis of Renal Oncocytic tumors in Core Biopsy Specimens.
Manini C; Imaz I; de Larrinoa AF; López JI
Curr Urol Rep; 2022 Nov; 23(11):327-333. PubMed ID: 36169870
[TBL] [Abstract] [Full Text] [Related]
10. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
[TBL] [Abstract] [Full Text] [Related]
11. TSC/MTOR -associated Eosinophilic Renal tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : A Targeted Next-generation Sequencing and Gene Expression Profiling Study.
Xia QY; Wang XT; Zhao M; He HY; Fang R; Ye SB; Li R; Wang X; Zhang RS; Lu ZF; Ma HH; Wang ZY; Rao Q
Am J Surg Pathol; 2022 Nov; 46(11):1562-1576. PubMed ID: 35980750
[TBL] [Abstract] [Full Text] [Related]
12. Risk Factors and Incidence of Malignancy After kidney Transplant in Mainland China: A Single-Center Analysis.
Liu D; Quan X; Ji H; Xing X; Zhou C; Jing F
Exp Clin Transplant; 2022 Jun; 20(6):558-563. PubMed ID: 35791829
[TBL] [Abstract] [Full Text] [Related]
13. Adverse Urinary System Diagnoses among Older Women with Endometrial Cancer.
Anderson C; Olshan AF; Park J; Bae-Jump VL; Brewster WR; Lund JL; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1368-1375. PubMed ID: 35545287
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery.
Bakkila BF; Kerekes D; Nunez-Smith M; Billingsley KG; Ahuja N; Wang K; Oladele C; Johnson CH; Khan SA
JAMA Netw Open; 2022 Apr; 5(4):e225664. PubMed ID: 35377425
[TBL] [Abstract] [Full Text] [Related]
15. Renal oncocytoma with prominent xanthomatous reaction. A rare histopathological variant of oncocytoma.
Val-Bernal JF; Garijo MF; Gómez-Román JJ
Rom J Morphol Embryol; 2021; 62(3):663-670. PubMed ID: 35263393
[TBL] [Abstract] [Full Text] [Related]
16. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
[TBL] [Abstract] [Full Text] [Related]
18. A CT-based radiomics nomogram for differentiation of small masses (< 4 cm) of renal oncocytoma from clear cell renal cell carcinoma.
Li X; Ma Q; Tao C; Liu J; Nie P; Dong C
Abdom Radiol (NY); 2021 Nov; 46(11):5240-5249. PubMed ID: 34268628
[TBL] [Abstract] [Full Text] [Related]
19. Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for kidney-sparing Strategies: An International Collaborative Study.
Marcq G; Foerster B; Abufaraj M; Matin SF; Azizi M; Gupta M; Li WM; Seisen T; Clinton T; Xylinas E; Mir MC; Schweitzer D; Mari A; Kimura S; Bandini M; Mathieu R; Ku JH; Guruli G; Grabbert M; Czech AK; Muilwijk T; Pycha A; D'Andrea D; Petros FG; Spiess PE; Bivalacqua T; Wu WJ; Rouprêt M; Krabbe LM; Hendricksen K; Egawa S; Briganti A; Moschini M; Graffeille V; Autorino R; John P; Heidenreich A; Chlosta P; Joniau S; Soria F; Pierorazio PM; Shariat SF; Kassouf W
Eur Urol Focus; 2022 Mar; 8(2):491-497. PubMed ID: 33773965
[TBL] [Abstract] [Full Text] [Related]
20. Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened kidney Function.
Kwiatkowski J; Kuliszkiewicz-Janus M; Rymer W; Jaźwiec B; Małecki R
Pharmacology; 2021; 106(5-6):316-322. PubMed ID: 33691325
[TBL] [Abstract] [Full Text] [Related]
[Next]
